Abstract
Background and Aim: Pharmacological treatment of nonalcoholic fatty liver disease (NAFLD) is still evolving. Mechanism of protection of liver injury by Phyllanthin is not clear. Dysregulation of PI3K/AKT pathway contributes to the development of non-alcoholic fatty liver disease (NAFLD). Aim of the study was to evaluate if hepatoprotective effectof Phyllanthin improving the liver histology in mice model of NAFLDis related to the regulation of NFKB/PI3K/AKTpathway.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call